洞察O-GlcNAcylation和癌症癌症中的编程细胞死亡
Xiaohan Yan1,2,3, Wenhao Ren1,3, Zhuang Zhu1,2,3
1Department of Oral and Maxillofacial Reconstruction, The Affiliated Hospital of Qingdao University, Qingdao, China.
Frontiers in cell and developmental biology
|October 8, 2025
概括
O-GlcNAcylation是一种蛋白质修饰,影响癌症的发展和抵抗力. 这篇评论探讨了它与编程细胞死亡 (PCD) 途径的联系,为新的抗癌疗法提供了见解.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- O-GlcNAcylation是一种关键的翻译后修饰,调节各种细胞过程.
- 异常的O-GlcNAcylation涉及癌症的各个方面,包括信号传递,新陈代谢和细胞分裂.
- 编程细胞死亡 (PCD) 涵盖了在癌症进展和治疗耐药性方面至关重要的多种受调节的细胞死亡途径.
研究的目的:
- 审查O-GlcNAcylation和不同的PCD路径之间的复杂联系.
- 阐明O-GlcNAcylation如何影响癌症的发病,进展和治疗耐药性.
- 为开发针对O-GlcNAcylation和PCD的改进的抗癌策略建立理论基础.
主要方法:
- 在癌症中对O-GlcNAcylation和PCD进行现有研究的文献综述和综合.
- 对将O-GlcNAcylation与亡,自,热亡,死亡和铁亡联系起来的研究分析.
- 整合发现,以突出O-GlcNAcylation在癌症生物学中的作用.
主要成果:
- O-GlcNAcylation显著调节多个PCD途径,影响癌细胞命运.
- O-GlcNAcylation和PCD之间的相互作用对于癌症的发病,进展和逃避治疗至关重要.
- 特定的PCD途径通过O-GlcNAcylation进行差异调节,影响瘤行为.
结论:
- 了解O-GlcNAcylation-PCD轴为癌症机制提供了一个新的视角.
- 针对O-GlcNAcylation与PCD途径结合,对未来的癌症疗法具有重大前景.
- 对这种关系的进一步研究可能会为癌症治疗提供新的临床应用.
关键词:
这是一种O-GlcNAcylation.灭症 (apoptosis) 是一种死亡的过程.自自是自的过程.癌症 癌症 癌症 癌症 癌症铁性化 (ferroptosis) 是一种尸体亡 (necroptosis) 是一种致死症.被编程的细胞死亡.热致灭 (pyroptosis) 是一种致的过程.更多相关视频
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
11.4K
10:03Author Spotlight: Understanding Cytokine-Induced Cell Death in Intestinal Epithelial Cells Using Human Organoids
Published on: August 2, 2024
2.0K
相关概念视频
01:30Overview of Cell Death
9.4K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
9.4K
01:31The Intrinsic Apoptotic Pathway
8.3K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.3K
01:30Apoptosis
14.1K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
14.1K
01:18Autophagic Cell Death
4.3K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.3K
03:03mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
01:22PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K